Luc M Berclaz

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 1

Top Topics

Randomized Controlled Trial

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Luc M Berclaz, Annelore Altendorf-Hofmann, Lars Hartwin Lindner, Anton Burkhard-Meier, Dorit Di Gioia, Hans-Roland Dürr, Alexander Klein, Markus Albertsmeier, Nina-Sophie Schmidt-Hegemann, Frederick Klauschen, Thomas Knösel
TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS). Cancers 15 (10) (2023)